Chugh to head division exploring AI in medicine at Cedars-Sinai

Cedars-Sinai announced its department of medicine has created a new division to examine applications of artificial intelligence in medicine, headed by Sumeet S. Chugh, MD.
Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research, has experience with using technology and population-based data to determine who may be at risk for sudden cardiac arrest, according to a press release from the institution.

“Through the use of applied artificial intelligence, we can solve existing gaps in mechanisms, diagnostics and therapeutics of major human disease conditions [that] afflict large populations,” Paul W. Noble, MD, professor of medicine and chair of the department of medicine at Cedars-Sinai, who created the new division, said in the release. “The future of medicine lies in decoding enormous amounts of phenotypic and genotypic patient data.”
Chugh said in the release that the division, Artificial Intelligence in Medicine (AIM), will draw from multiple disciplines.
“Using a disease-based approach, AIM will enable cross-disciplinary connections between clinicians, scientists, and trainees at Cedars-Sinai at multiple levels,” he said in the release.
Initial research from the division has included applying AI algorithms to predict MI risk in patients with CAD and creating an AI tool to identify and distinguish between hypertrophic cardiomyopathy and cardiac amyloidosis, according to the release.